Literature DB >> 11220296

Glucose and fatty acid metabolism in type 2 diabetes mellitus: an assessment using low-dose insulin infusion and the hyperinsulinaemic euglycaemic clamp.

J Webber1, D Whitelaw, J M Smith, M Nattrass.   

Abstract

AIM: To assess whether resistance to the effects of insulin on lipid metabolism in type 2 diabetes mellitus parallels that demonstrated for glucose metabolism.
METHODS: Thirteen patients with type 2 diabetes were studied (mean age 56.2 years, mean body mass index (b.m.i.) 28.7 kg m(-2)). The hyperinsulinaemic euglycaemic clamp (2 mU insulin kg(-1) min(-1)) and a low-dose insulin infusion technique were used in order to assess insulin effects on both glucose and lipid metabolism.
RESULTS: Using the low-dose insulin infusion there were significant correlations between measures of insulin sensitivity for glucose metabolism and those for NEFA (r = 0.82, p < 0.01) and glycerol (r = 0.73, p < 0.01). Mean clamp glucose disposal was 33.4 micromol kgb.w.(-1) min(-1). There was no correlation between clamp glucose disposal and insulin sensitivity derived from the low-dose insulin infusion.
CONCLUSIONS: At low insulin concentrations, insulin's effects on glucose metabolism (mainly suppression of hepatic glucose output) mirror those on inhibition of lipolysis. At the high insulin concentrations seen during the clamp, stimulation of glucose uptake provides a measure of maximal insulin action which does not parallel its physiological effects shown at lower concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11220296     DOI: 10.1046/j.1463-1326.1999.00011.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  2 in total

1.  Glucose clearance is higher in arm than leg muscle in type 2 diabetes.

Authors:  David B Olsen; Massimo Sacchetti; Flemming Dela; Thorkil Ploug; Bengt Saltin
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

2.  Adipose tissue insulin resistance in adolescents with and without type 2 diabetes.

Authors:  M M Kelsey; J E Forster; R E Van Pelt; J E B Reusch; K J Nadeau
Journal:  Pediatr Obes       Date:  2013-07-17       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.